Menu
image description

Tag: Target Identification in Lupus

LRA Research Director Presents at ACR Roundtable

October 22, 2018 Our Research Director, Dr. Teodora Staeva, presented at the “Meet the Funders: NIH & Foundation Roundtable Grant Discussion” October 22 at the American College of Rheumatology (ACR) annual meeting. Dr. Staeva spoke about the Lupus Research Alliance many grant programs available to scientists including the  Target Identification in Lupus, Novel Research Grant, Analysis of Lupus […] Read More

Potential Treatment for Sun Damage Discovered with LRA Funding

August 16, 2018 Exposure to the sun is hard on everyone’s skin, causing cells to die. But skin cells are much more vulnerable in people with lupus.  That reaction is called photosensitivity. A team of scientists led by Theresa Lu, MD, PhD, at Hospital for Special Surgery (HSS) in New York may have discovered why. […] Read More

Potential New Lupus Treatment Outperforms Hydroxychloroquine in Animal Study

November 28, 2018 Anti-malaria drugs such as hydroxychloroquine are common treatments for arthritis and heat rash in patients with lupus. A new study by Target Identification in Lupus grantee Keith Elkon, MD, of the University of Washington, Seattle, and colleagues suggests that a new drug they designed works better than the commonly prescribed hydroxychloroquine in […] Read More

Bold Initiatives … Tremendous Strides Breaking Through on Lupus Research

In 2018 the Lupus Research Alliance has taken daring chances, pursued bold initiatives, and made tremendous strides! We truly are breaking through on many pioneering fronts of lupus research — thanks to the unwavering generosity of donors at all levels of support. Throughout the year, the brilliant scientists we brought to the table ushered in […] Read More

Microchip Technology Charts New Ground

Sept. 7, 2017.  The study of T cells and B cells, their function, and the interaction between them that causes runaway inflammation and the progression of disease have been the subjects of numerous groundbreaking lupus investigations over the past decade. Today, Rong Fan, PhD, from Yale University, is building on these discoveries by using his […] Read More

New TIL Grantees Offer Novel Approaches

Sept. 7, 2017.  Grantees of our Target Identification in Lupus (TIL) program are remarkable scientific investigators whose ingenuity and determination are bringing new insights to lupus research. The Lupus Research Alliance congratulates each of these brilliant researchers in their quest to expand our understanding of lupus and ways to defeat it: Kerstin Nundel, PhD University […] Read More